Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanoma differentiation-associated gene 5 (MDA5) is a cytosolic pattern recognition receptor that plays a crucial role in the innate immune response to viral infection. It detects long double-stranded RNA (dsRNA) and initiates antiviral responses by inducing type I interferons. Aberrant activity is linked to autoimmune diseases like dermatomyositis.
Not applicable, MDA5 is a target and not a drug
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoma differentiation-associated gene 5.